Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 2Phase 3 1Phase 1 1

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Endocrine 3

Conditions

Multiple Endocrine Neoplasia Type 1 96Pituitary Neoplasms 57Neuroendocrine Tumors 50Thyroid Cancer, Papillary 42Thyroid Neoplasms 16Obesity 15Pheochromocytoma 14Overweight 11Adrenal Gland Neoplasms 10Weight Loss 9Paraganglioma 9Carcinoma, Neuroendocrine 9Pancreatic Neoplasms 8Prostatic Neoplasms 7Motor Activity 7Insulinoma 7Gastrointestinal Neoplasms 7Brain Neoplasms 7Adrenocortical Adenoma 7Acquired Immunodeficiency Syndrome 7Neoplasm Metastasis 6Hyperaldosteronism 6Carcinoma, Medullary 6Stomach Neoplasms 5Osteoporosis 5Neoplasms 5Meningioma 5Liver Neoplasms 5Insulin Resistance 5HIV Infections 5

Interventions

Early Intervention, Educational 1Diet, Mediterranean 1Diet, Ketogenic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Growth Hormone-Secreting Pituitary Adenoma × Endocrine × Clear all
NCT06949891 2025-04-29

KETOACRO

Erasmus Medical Center

Phase NA Recruiting
60 enrolled
Endocrine

Growth Hormone-Secreting Pituitary Adenoma

NCT03807076 2023-11-29

GA-9

University of Copenhagen

Phase NA Completed
25 enrolled
Endocrine

Growth Hormone-Secreting Pituitary Adenoma

NCT01775332 2015-07-31

Interdisciplinary Pituitary Disorders Centre of Excellence: Assessment of Patient Education Tools

Unity Health Toronto

Phase NA Unknown
60 enrolled
Endocrine

Gigantism, Pituitary Neoplasms, Prolactinoma, Growth Hormone-Secreting Pituitary Adenoma, ACTH-Secreting Pituitary Adenoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡